UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> WHO Launches Initiative To End Malaria in 25 Countries On The Cusp Of Disease Elimination 22/04/2021 Madeleine Hoecklin Progress towards global malaria targets has stalled in recent years, and the COVID-19 pandemic has posed a serious threat to malaria responses worldwide, but a number of countries are nearing the goal of zero cases of malaria, said WHO, in a forum convened just ahead of World Malaria Day on 25 April. The forum Reaching Zero: […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> COVID-19 Provides Lessons for TB Vaccine Development 20/04/2021 Kerry Cullinan Encouraged by how fast vaccines have been developed for COVID-19, tuberculosis advocates launched a “TB vaccine roadmap” on Tuesday and aim to use lessons from the pandemic to jumpstart the quest for a TB vaccine. The purpose of the roadmap, said Frank Cobelens of the Amsterdam Institute for Global Health and Development, is to provide […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launches Initiative To End Malaria in 25 Countries On The Cusp Of Disease Elimination 22/04/2021 Madeleine Hoecklin Progress towards global malaria targets has stalled in recent years, and the COVID-19 pandemic has posed a serious threat to malaria responses worldwide, but a number of countries are nearing the goal of zero cases of malaria, said WHO, in a forum convened just ahead of World Malaria Day on 25 April. The forum Reaching Zero: […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> COVID-19 Provides Lessons for TB Vaccine Development 20/04/2021 Kerry Cullinan Encouraged by how fast vaccines have been developed for COVID-19, tuberculosis advocates launched a “TB vaccine roadmap” on Tuesday and aim to use lessons from the pandemic to jumpstart the quest for a TB vaccine. The purpose of the roadmap, said Frank Cobelens of the Amsterdam Institute for Global Health and Development, is to provide […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> COVID-19 Provides Lessons for TB Vaccine Development 20/04/2021 Kerry Cullinan Encouraged by how fast vaccines have been developed for COVID-19, tuberculosis advocates launched a “TB vaccine roadmap” on Tuesday and aim to use lessons from the pandemic to jumpstart the quest for a TB vaccine. The purpose of the roadmap, said Frank Cobelens of the Amsterdam Institute for Global Health and Development, is to provide […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> COVID-19 Provides Lessons for TB Vaccine Development 20/04/2021 Kerry Cullinan Encouraged by how fast vaccines have been developed for COVID-19, tuberculosis advocates launched a “TB vaccine roadmap” on Tuesday and aim to use lessons from the pandemic to jumpstart the quest for a TB vaccine. The purpose of the roadmap, said Frank Cobelens of the Amsterdam Institute for Global Health and Development, is to provide […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Provides Lessons for TB Vaccine Development 20/04/2021 Kerry Cullinan Encouraged by how fast vaccines have been developed for COVID-19, tuberculosis advocates launched a “TB vaccine roadmap” on Tuesday and aim to use lessons from the pandemic to jumpstart the quest for a TB vaccine. The purpose of the roadmap, said Frank Cobelens of the Amsterdam Institute for Global Health and Development, is to provide […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Posts navigation Older postsNewer posts